MedPath

上海复旦复华药业有限公司

Ownership
-
Established
1981-12-01
Employees
-
Market Cap
-
Website
http://www.fudanforwardpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

83

NMPA:83

Drug Approvals

盐酸硫必利片

Approval Number
国药准字H31022306
Approval Date
Aug 15, 2024
NMPA

雷公藤多苷片

Approval Number
国药准字Z31020415
Approval Date
Aug 5, 2024
NMPA

维生素B2片

Approval Number
国药准字H31021369
Approval Date
Jul 30, 2024
NMPA

维生素B1片

Approval Number
国药准字H31021542
Approval Date
Jul 30, 2024
NMPA

甲氧氯普胺片

Approval Number
国药准字H31021209
Approval Date
Jul 30, 2024
NMPA

甲溴阿托品片

Approval Number
国药准字H31022305
Approval Date
Jul 30, 2024
NMPA

利血平片

Approval Number
国药准字H31021367
Approval Date
Jul 30, 2024
NMPA

复合维生素B片

Approval Number
国药准字H31021411
Approval Date
Jul 24, 2024
NMPA

Cyproheptadine Hydrochloride Tablets

Product Name
盐酸赛庚啶片
Approval Number
国药准字H31021372
Approval Date
May 7, 2024
NMPA

卡马西平片

Approval Number
国药准字H31021366
Approval Date
Apr 23, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.